InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,509.01
(
0.62%
)
US TECH 100
19,479.20
(
1.05%
)
Dow Jones
39,331.85
(
0.41%
)
Brent Oil
86.36
(
-0.20%
)
Bitcoin
61,927.89
(
-1.47%
)
Post# of 690
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

sharkey1

Send PM Follow Ignore
Followers 55
Posts 8812
Boards Moderated 0
Alias Born 12/01/2010

sharkey1

Re: None

Monday, 04/18/2022 12:35:10 PM

Monday, April 18, 2022 12:35:10 PM

Post# of 690
Lets get real with Doxy, there was a shortage, and could be now due to API probs, so much demand, look at the list,

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=browseByLetter.page&productLetter=D

maybe that's why Nasrat wasn't so enthusiatic about this approval, and didn't want to purse it further, could be the next big thing, but until we see a partner, some one who can take it on, and make a difference. The antibiotic saves lives.

it's like, Who you gonna call,

Hopefully Dexcell
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up